V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013087 | 220007534 | 1.7 | 63 | null | 2016-01-08 | 2016-01-10 | CYTARABINE | N | N | 220029068 | CYTARABINE |
| 220013088 | 220014147 | 1.71 | 57.3 | Disease modification (D) | null | 2015-03-02 | AML MyeChild 01 FLA-Idarubicin | N | N | 220029069 | NOT MATCHED |
| 220013090 | 220007536 | null | 65.5 | Palliative (P) | 2015-08-25 | 2015-12-20 | Cytarabine Low Dose | 02 | N | 220029078 | CYTARABINE |
| 220013091 | 220007537 | 1.6 | 22.7 | Curative (C) | 2013-11-29 | 2013-12-04 | AML Relapsed FLA - DaunoXome | N | N | 220029081 | NOT MATCHED |
| 220013092 | 220014149 | 1.66 | 9.5 | Palliative (P) | 2017-04-25 | 2017-05-09 | CYTARABINE + ETOPOSIDE + MITOXANTRONE | N | N | 220029081 | NOT MATCHED |
| 220013093 | 220014149 | null | 0 | Disease modification (D) | 2014-04-03 | 2014-04-03 | Hydroxycarbamide | N | null | 220029081 | HYDROXYCARBAMIDE |
| 220013094 | 220014149 | null | null | Curative (C) | 2016-04-13 | 2016-04-13 | Hydroxycarbamide | N | N | 220029081 | HYDROXYCARBAMIDE |
| 220013095 | 220007538 | null | 10 | Disease modification (D) | 2014-10-22 | 2014-10-27 | AML MyeChild 01 A Mitozantrone/Cytarabine | N | N | 220029091 | NOT MATCHED |
| 220013096 | 220007540 | 1.25 | 0 | Palliative (P) | 2014-04-12 | 2014-04-16 | Hydroxycarbamide | N | N | 220029092 | HYDROXYCARBAMIDE |
| 220013097 | 220007541 | null | 87.8 | Curative (C) | 2012-09-30 | 2013-06-07 | Cytarabine Low Dose | N | N | 220029095 | CYTARABINE |
| 220013098 | 220007542 | 1.78 | null | Curative (C) | 2014-05-11 | 2014-05-14 | CYTARABINE | 2 | N | 220029096 | CYTARABINE |
| 220013099 | 220007544 | 0 | null | Disease modification (D) | null | 2018-10-19 | Hydroxycarbamide | N | N | 220029098 | HYDROXYCARBAMIDE |
| 220013100 | 220007545 | 0 | 62.8 | Curative (C) | 2015-08-11 | 2015-08-11 | Hydroxycarbamide | N | N | 220029102 | HYDROXYCARBAMIDE |
| 220013101 | 220007546 | 1.76 | 53.6 | Disease modification (D) | null | 2015-05-05 | Hydroxycarbamide | N | N | 220029103 | HYDROXYCARBAMIDE |
| 220013102 | 220007547 | null | 34.25 | Palliative (P) | 2016-06-30 | 2016-08-18 | Hydroxycarbamide | 2 | N | 220029109 | HYDROXYCARBAMIDE |
| 220013103 | 220007547 | null | null | Disease modification (D) | null | 2014-01-08 | Cytarabine Low Dose | N | null | 220029109 | CYTARABINE |
| 220013104 | 220007547 | 0 | 54 | Curative (C) | 2017-07-31 | 2017-08-04 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | 02 | N | 220029109 | NOT MATCHED |
| 220013105 | 220007549 | null | null | Palliative (P) | 2014-04-23 | 2014-04-23 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220029118 | CYTARABINE |
| 220013106 | 220007551 | null | null | Disease modification (D) | null | 2015-08-01 | CYTARABINE | 2 | N | 220029122 | CYTARABINE |
| 220013107 | 220007551 | 1.62 | 8.6 | Palliative (P) | 2016-12-02 | 2016-12-04 | null | 02 | null | 220029122 | NOT MATCHED |
| 220013109 | 220007557 | 1.69 | null | Disease modification (D) | 2013-09-06 | 2013-09-06 | Hydroxycarbamide | 02 | N | 220029145 | HYDROXYCARBAMIDE |
| 220013110 | 220007557 | 1.25 | 43 | null | 2013-09-20 | 2013-09-21 | ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | 02 | null | 220029145 | NOT MATCHED |
| 220013111 | 220007557 | 1.52 | 50 | Palliative (P) | 2016-04-10 | 2016-04-10 | CYTARABINE | N | N | 220029145 | CYTARABINE |
| 220013112 | 220007558 | null | 0 | Disease modification (D) | 2016-05-13 | 2016-05-14 | Hydroxycarbamide | 02 | N | 220029150 | HYDROXYCARBAMIDE |
| 220013113 | 220007559 | null | 62.8 | Palliative (P) | 2018-09-02 | 2018-09-02 | Hydroxycarbamide | 02 | N | 220029152 | HYDROXYCARBAMIDE |
| 220013114 | 220007560 | null | 0 | Palliative (P) | 2017-10-26 | 2017-11-10 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 220029155 | NOT MATCHED |
| 220013115 | 220007561 | 1.08 | 81.7 | Disease modification (D) | 2018-09-17 | 2018-09-17 | Hydroxycarbamide | 2 | N | 220029155 | HYDROXYCARBAMIDE |
| 220013116 | 220017721 | null | 63.3 | Palliative (P) | 2014-04-25 | 2014-09-02 | Hydroxycarbamide | N | Y | 220029163 | HYDROXYCARBAMIDE |
| 220013119 | 220017723 | 1.53 | 87.5 | Curative (C) | 2013-05-04 | 2013-11-04 | Hydroxycarbamide | N | null | 220029170 | HYDROXYCARBAMIDE |
| 220013120 | 220007566 | null | 0 | Palliative (P) | 2015-05-31 | 2015-05-31 | Hydroxycarbamide | 02 | null | 220029176 | HYDROXYCARBAMIDE |
| 220013121 | 220007566 | 1.7 | 64 | Palliative (P) | 2014-08-07 | 2014-08-07 | Hydroxycarbamide | 2 | N | 220029176 | HYDROXYCARBAMIDE |
| 220013122 | 220007566 | 1.76 | null | Curative (C) | 2016-06-24 | 2016-09-06 | CYTARABINE | 02 | N | 220029176 | CYTARABINE |
| 220013123 | 220007567 | 1.52 | 59.1 | null | 2016-03-27 | 2017-04-30 | Hydroxycarbamide | Y | N | 220029179 | HYDROXYCARBAMIDE |
| 220013124 | 220007567 | 0 | 113 | Disease modification (D) | 2015-11-28 | 2015-11-29 | Hydroxycarbamide | N | N | 220029179 | HYDROXYCARBAMIDE |
| 220013125 | 220007568 | 1.62 | 43.4 | Palliative (P) | null | 2015-08-28 | Cytarabine Low Dose | N | N | 220029185 | CYTARABINE |
| 220013126 | 220014166 | 1.04 | 76.4 | Disease modification (D) | null | 2015-04-17 | Enasidenib + Enasidenib | N | N | 220029188 | NOT MATCHED |
| 220013127 | 220007570 | 1.63 | 68.8 | Palliative (P) | null | 2017-10-31 | CYTARABINE | 2 | N | 220029190 | CYTARABINE |
| 220013128 | 220014167 | 1.04 | 18.3 | Curative (C) | 2014-08-01 | 2014-08-07 | null | null | N | 220029191 | NOT MATCHED |
| 220013129 | 220014167 | null | 66.8 | Disease modification (D) | 2017-05-30 | 2017-05-30 | Hydroxycarbamide | null | null | 220029191 | HYDROXYCARBAMIDE |
| 220013130 | 220014167 | 0 | 65 | Disease modification (D) | 2014-01-03 | 2014-01-04 | CYTARABINE | 02 | N | 220029191 | CYTARABINE |
| 220013132 | 220007572 | null | 51.5 | Curative (C) | 2013-06-17 | 2013-06-28 | CYTARABINE | N | null | 220029203 | CYTARABINE |
| 220013133 | 220007573 | 1.04 | 109.1 | Palliative (P) | 2017-02-22 | 2017-02-22 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220029205 | CYTARABINE |
| 220013134 | 220007574 | 1.59 | null | Palliative (P) | 2015-08-16 | 2015-08-17 | CYTARABINE | null | N | 220029214 | CYTARABINE |
| 220013135 | 220007574 | 1.61 | 68 | Palliative (P) | 2015-11-17 | 2015-11-17 | Hydroxycarbamide | N | N | 220029214 | HYDROXYCARBAMIDE |
| 220013136 | 220007574 | 1.54 | 74.7 | Not known (9) | 2016-07-19 | 2016-07-19 | CYTARABINE | N | null | 220029214 | CYTARABINE |
| 220013137 | 220019721 | 1.6 | 12.3 | Palliative (P) | null | 2014-02-13 | AML Interim Guidelines FLA | N | null | 220029230 | NOT MATCHED |
| 220013138 | 220007575 | 0 | null | Palliative (P) | 2015-07-10 | 2015-07-12 | CYTARABINE | N | N | 220029232 | CYTARABINE |
| 220013139 | 220014169 | 1.79 | 113 | Palliative (P) | null | 2015-06-14 | Cytarabine Low Dose | N | N | 220029234 | CYTARABINE |
| 220013140 | 220007577 | 0 | 8.8 | Not known (9) | 2013-03-23 | 2013-03-30 | AML MyeChild 01 FLA | 02 | N | 220029235 | NOT MATCHED |
| 220013141 | 220007578 | 1.72 | 80 | null | 2018-10-02 | 2018-10-10 | Cytarabine Low Dose | N | N | 220029242 | CYTARABINE |